FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20289811000001101: Ibandronic acid 50mg tablets (Sandoz Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Apr 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68357201000001116 Ibandronic acid 50mg tablets (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68357301000001113 Ibandronic acid 50mg tablets (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibandronic acid 50mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Is a Ibandronic acid 50mg tablets true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Is a Ibandronic acid 50mg tablets false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Is a Product containing precisely ibandronic acid 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has active ingredient Ibandronic acid false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has specific active ingredient Ibandronic sodium monohydrate false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Sandoz Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ibandronic acid 50mg tablets (Sandoz Ltd) 28 tablet Has AMP True Ibandronic acid 50mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start